[
    [
        {
            "time": "",
            "original_text": "中小盘伐谋主题：体外诊断(IVD)行业系列五：流水线 体外诊断皇冠上的明珠",
            "features": {
                "keywords": [
                    "体外诊断",
                    "IVD",
                    "流水线",
                    "行业系列"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "体外诊断"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "中小盘伐谋主题：体外诊断(IVD)行业系列五：流水线 体外诊断皇冠上的明珠",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "[看好评级] 医药行业2018年中期投资策略：医药一枝独秀上半年全面牛 短暂调整后下半年看结构牛行情",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资策略",
                    "2018年中期",
                    "全面牛",
                    "结构牛"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[看好评级] 医药行业2018年中期投资策略：医药一枝独秀上半年全面牛 短暂调整后下半年看结构牛行情",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "生物制品行业周报: 复星医药控股子公司签署许可协议",
            "features": {
                "keywords": [
                    "生物制品",
                    "复星医药",
                    "控股子公司",
                    "许可协议"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物制品",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "生物制品行业周报: 复星医药控股子公司签署许可协议",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]